Powered Surgical Staplers Segment to Dominate Product Segment of Surgical Stapling Devices Market
According to our new research study on "Surgical Stapling Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Type, Application, and End User," the market is expected to grow from US$ 4,795.83 million in 2022 to US$ 7,747.1 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2022 to 2028. Key factors driving the market growth are increase in wounds & surgical procedures and new product launches & strategic collaborations. However, increase in product recalls and high cost of surgical stapling devices are restricting the market growth.
The companies engaged in the surgical stapling devices market witnessed an adverse impact on their services in early 2020 due to the temporary shutdown of their laboratories. Supply chain and manufacturing activities were disrupted globally due to lockdowns implemented by governments, restricted movement, and other COVID-19 safety precautions. On the other hand, new infections have tripled in numerous states in southern Mexico. The pandemic of coronavirus disease 2019 (COVID-19) has increased hospital resource use and necessitated the postponement of elective surgical procedures. The increasing number of cases has resulted in decrease in the number of routine patient visits to hospitals and clinics, as well as a decrease in the number of elective surgeries performed each week. According to an article in Ophthalmology Times, the number of elective procedures has decreased from 200 to only 10 each week. Additionally, the closure of manufacturing units and halted operations has further affected the production and supply chain of the surgical stapling devices are further expected to negatively impact the market growth.
The product segment in the surgical stapling devices market is bifurcated into powered surgical staplers and manual surgical staplers. The powered surgical staplers is expected to hold the largest market share in 2022 and is estimated to register the highest CAGR during 2022-2028. Powered surgical staplers are preferred over manual staplers owing to ease of use, low risk of problems such as blood loss or spillages, shorter operating times, and lower hospital costs. The powered surgical staplers segment is driven by several advantages such as precise wound closure, stability, fewer leaks, and lower compressive force. Currently, two types of powered stapling systems are predominantly used in clinical practice-Ethicon's GST and Medtronic's Signia Stapling System (SIG). GST, launched in 2015, has reloaded surfaces with proprietary pocket extensions to stabilize and hold in place tissue to deploy staples with uniform height. SIG, launched in 2017, combines a Medtronic-powered stapler handle and other components (such as linear adapter, power shell, stapler insertion guide, and manual retraction tool) representing a redesign from the original Endo-GIATM iDrive powered stapler while maintaining same original stapler reloads with Tri-Staple technology. In 2021, Ethicon launched ECHELON+ Stapler with GST Reloads, a new powered surgical stapler designed to increase staple line security and reduce complications by more uniform tissue compression and better staple formation, even in challenging situations. Hence, due to the rising demand for advanced technology, the powered surgical stapler device segment held a larger share in 2022 and is predicted to grow quickly during the forecast period.
North America is leading the surgical stapling devices market due to growing geriatric population, favorable healthcare reforms, and surgical procedures performed in large numbers every year. According to the Journal of Thoracic Disease, ~530,000 general thoracic surgeries are performed yearly in the US by ~4,000 cardiothoracic surgeons. According to the American Joint Replacement Registry (AJRR), it is estimated that ~3.48 million people would require knee replacement by 2030. This is significantly affecting the sales of surgical stapling devices. The key companies operating in the surgical stapling devices market focus on organic and inorganic growth strategies such as product launches and product approvals. They are adopting various methods such as mergers and acquisitions, advanced product development, and collaborations to gain a competitive edge in the market. For instance, In June 2022, Ethicon, part of Johnson & Johnson MedTech, launched ECHELON 3000 Stapler in the US. It is a digitally enabled device that provides surgeons with simple, one-handed powered articulation to help address the unique needs of their patients. Designed with 39% greater jaw aperture and a 27% greater articulation span, ECHELON 3000 gives surgeons better access and control over each transection, even in tight spaces and on challenging tissue. Combined with software that provides real-time haptic and audible device feedback, these features enable surgeons to make critical adjustments during procedures. Therefore, the factors discussed are expected to generate demand for surgical stapling devices and support the overall market growth in the region.
Intutive Surgical Inc., Medtronic Plc, Ethicon USA LLC, Frankenman International Ltd, Panther Healthcare Medical Equipment Co Ltd, B. Braun SE, Grena Ltd, Conmed Corp, 3M Co, and Purple Surgical UK Ltd are among the key companies operating in the surgical stapling devices market.
The report segments the Surgical Stapling Devices market as follows:
The surgical stapling devices market is segmented based on product, type, application, end user, and geography. Based on product, the market is segmented into powered surgical staplers and manual surgical staplers. Based on type, the market is segmented into disposable surgical staplers and reusable surgical staplers. Based on applicaton, the market is segmented into orthopedic surgery, endoscopic surgery, cardiac and thoracic surgery, abdominal and pelvic surgery, and others. Based on end user, the surgical stapling devices market is segmented into hospitals and ambulatory surgical centers. Based on geography, the surgical stapling devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com